DE:2RH Stock Latest News
Company AnnouncementsRedHill Biopharma Regains Global Rights to RHB-102 After Hyloris Deal Termination1w ago6KRDHL
Company AnnouncementsRedHill Biopharma Backs $2.9 Million NCI-Funded Opaganib–CAR T Trial in Ultra-High-Risk Myeloma1w ago6KRDHL
Company AnnouncementsRedHill Biopharma Expands U.S. ATM ADS Offering With New Prospectus Supplement2w ago6KRDHL
Company AnnouncementsRedHill Biopharma Wins Nasdaq Bid-Price Compliance Extension to April 20273w ago6KRDHL
Company AnnouncementsRedHill Biopharma Reshapes GI Portfolio With Asset Sale and New Licensing Deals1M ago6KRDHL
Company AnnouncementsRedHill Biopharma Reshapes GI Portfolio With Rebyota, Clenpiq Deal and Talicia Sale1M ago6KRDHL
Company AnnouncementsRedHill Biopharma Sells Talicia Stake to Apotex for $18 Million Upfront2M ago6KRDHL
Company AnnouncementsRedHill Biopharma Shareholders Approve Leadership Changes and Share Structure Amendment2M ago6KRDHL
Company AnnouncementsRedHill Biopharma Advances Opaganib as Ebola Outbreak Worsens3M ago6KRDHL
Company AnnouncementsRedHill Biopharma Reschedules 2026 AGM to Add Proposal, Seeks Approval to Scrap Par Value4M ago6KRDHL
Company AnnouncementsRedHill Biopharma Expands ATM ADS Offering Capacity in U.S. Market4M ago6KRDHL
Company AnnouncementsRedHill Biopharma Sets July 28, 2026 AGM to Vote on Board, Auditor and Chairman-CEO Role4M ago6KRDHL
Company AnnouncementsRedHill Biopharma Closes $6 Million Private Placement to Fund Potential Acquisition4M ago6KRDHLCompany AnnouncementsRedHill Biopharma Raises $6 Million in June 2026 Private Placement of ADSs and Warrants4M ago6KRDHL
Company AnnouncementsRedHill Biopharma Sets July 28, 2026 Shareholder Meeting to Vote on Board, CEO-Chairman Role4M ago6KRDHL
